Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Ebiomedicine
|
November 22, 2024
Advancing respiratory virus diagnostics: integrating the nasal IFN-I score for improved viral detection
Marine Mommert-Tripon, Delphine Parraud, Cloé Grosbois, et al.
Scientific Reports
|
September 24, 2021
Publisher Correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study
Antonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, et al.
Scientific Reports
|
July 23, 2021
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study
Antonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, et al.
Frontiers in Immunology
|
November 17, 2022
A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients
Claire Tardiveau, Guillaume Monneret, Anne-Claire Lukaszewicz, et al.
Emerging Microbes & Infections
|
September 13, 2022
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
Carla Saade, Karen Brengel-Pesce, Alexandre Gaymard, et al.
The Journal of Experimental Medicine
|
August 20, 2021
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
Jonathan Lopez, Marine Mommert, William Mouton, et al.
The Journal of Experimental Medicine
|
August 6, 2021
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
Jonathan Lopez, Marine Mommert, William Mouton, et al.
Ebiomedicine
|
March 29, 2022
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19
Fabienne Venet, Morgane Gossez, Frank Bidar, et al.
Oncotarget
|
May 17, 2018
Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)
Jessica Garcia, Julien Forestier, Eric Dusserre, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Ebiomedicine
|
November 22, 2024
Advancing respiratory virus diagnostics: integrating the nasal IFN-I score for improved viral detection
Marine Mommert-Tripon, Delphine Parraud, Cloé Grosbois, et al.
Scientific Reports
|
September 24, 2021
Publisher Correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study
Antonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, et al.
Scientific Reports
|
July 23, 2021
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study
Antonin Bal, Karen Brengel-Pesce, Alexandre Gaymard, et al.
Frontiers in Immunology
|
November 17, 2022
A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients
Claire Tardiveau, Guillaume Monneret, Anne-Claire Lukaszewicz, et al.
Emerging Microbes & Infections
|
September 13, 2022
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
Carla Saade, Karen Brengel-Pesce, Alexandre Gaymard, et al.
The Journal of Experimental Medicine
|
August 20, 2021
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
Jonathan Lopez, Marine Mommert, William Mouton, et al.
The Journal of Experimental Medicine
|
August 6, 2021
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
Jonathan Lopez, Marine Mommert, William Mouton, et al.
Ebiomedicine
|
March 29, 2022
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19
Fabienne Venet, Morgane Gossez, Frank Bidar, et al.
Oncotarget
|
May 17, 2018
Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)
Jessica Garcia, Julien Forestier, Eric Dusserre, et al.
Page
of 3